| Item Type | Name |
|
Academic Article
|
Surgical management of atherosclerotic renovascular disease.
|
|
Academic Article
|
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.
|
|
Academic Article
|
Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study.
|
|
Academic Article
|
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
|
|
Academic Article
|
A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease.
|
|
Academic Article
|
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
|
|
Academic Article
|
Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis.
|
|
Academic Article
|
The impact of pedigree structure on heritability estimates for pulse pressure in three studies.
|
|
Academic Article
|
Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis.
|
|
Academic Article
|
Kidney volume associations with subclinical renal and cardiovascular disease: the Diabetes Heart Study.
|
|
Academic Article
|
Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes.
|
|
Academic Article
|
Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study.
|
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
|
Academic Article
|
Basic performance of an enzymatic method for glycated albumin and reference range determination.
|
|
Academic Article
|
Effects of rare and common blood pressure gene variants on essential hypertension: results from the Family Blood Pressure Program, CLUE, and Atherosclerosis Risk in Communities studies.
|
|
Academic Article
|
Assessing glycemic control in diabetic patients with severe nephropathy.
|
|
Academic Article
|
Glycemic control in patients with diabetes and nephropathy.
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Blood Chemical Analysis
|
|
Concept
|
National Heart, Lung, and Blood Institute (U.S.)
|
|
Concept
|
Blood Flow Velocity
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Blood Vessels
|
|
Concept
|
Blood Pressure Determination
|
|
Concept
|
Blood Proteins
|
|
Academic Article
|
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.
|
|
Academic Article
|
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
|
|
Academic Article
|
Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.
|
|
Academic Article
|
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes.
|
|
Academic Article
|
Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.
|
|
Academic Article
|
Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind.
|
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
|
Academic Article
|
Genome-Wide Interaction with Insulin Secretion Loci Reveals Novel Loci for Type 2 Diabetes in African Americans.
|
|
Academic Article
|
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
|
|
Academic Article
|
Genetics: Genetic factors in the regulation of blood pressure.
|
|
Academic Article
|
Research Needs to Improve Hypertension Treatment and Control in African Americans.
|
|
Academic Article
|
APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
|
|
Grant
|
Cerebrovascular Disease and Cognitive Performance in African Americans
|
|
Grant
|
Natural History of MYH9-Associated Nephropathy
|
|
Grant
|
Continuation of the FIND Study
|
|
Grant
|
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
|
|
Academic Article
|
Effects of Intensive BP Control in CKD.
|
|
Academic Article
|
Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus.
|
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
|
|
Academic Article
|
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
|
|
Academic Article
|
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
|
|
Academic Article
|
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
|
|
Academic Article
|
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
|
Academic Article
|
A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure.
|
|
Academic Article
|
Glycated albumin and blood sugar control in advanced chronic kidney disease.
|
|
Academic Article
|
Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity.
|
|
Academic Article
|
Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.
|
|
Academic Article
|
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
|
|
Academic Article
|
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
|
|
Academic Article
|
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
|
|
Academic Article
|
Blood-based bioenergetic profiling is related to differences in brain morphology in African Americans with Type 2 diabetes.
|
|
Academic Article
|
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Gene-educational attainment interactions in a multi-ancestry genome-wide meta-analysis identify novel blood pressure loci.
|
|
Academic Article
|
The impact of chronic kidney disease on cerebral hemodynamics: A transcranial Doppler study.
|
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations.
|
|
Academic Article
|
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT.
|
|
Academic Article
|
Inherited causes of clonal haematopoiesis in 97,691 whole genomes.
|